Novavax Inc (NVAX)
9.35
-0.26
(-2.71%)
USD |
NASDAQ |
Nov 01, 16:00
9.42
+0.07
(+0.75%)
After-Hours: 20:00
Novavax Total Assets (Quarterly): 1.819B for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.819B |
| March 31, 2024 | 1.354B |
| December 31, 2023 | 1.797B |
| September 30, 2023 | 1.657B |
| June 30, 2023 | 1.685B |
| March 31, 2023 | 1.543B |
| December 31, 2022 | 2.259B |
| September 30, 2022 | 2.267B |
| June 30, 2022 | 2.623B |
| March 31, 2022 | 2.835B |
| December 31, 2021 | 2.577B |
| September 30, 2021 | 2.566B |
| June 30, 2021 | 2.750B |
| March 31, 2021 | 2.608B |
| December 31, 2020 | 1.582B |
| September 30, 2020 | 944.02M |
| June 30, 2020 | 932.23M |
| March 31, 2020 | 328.07M |
| December 31, 2019 | 172.96M |
| September 30, 2019 | 164.81M |
| June 30, 2019 | 189.39M |
| March 31, 2019 | 221.32M |
| December 31, 2018 | 207.98M |
| September 30, 2018 | 250.48M |
| June 30, 2018 | 285.81M |
| Date | Value |
|---|---|
| March 31, 2018 | 276.07M |
| December 31, 2017 | 302.49M |
| September 30, 2017 | 334.08M |
| June 30, 2017 | 355.71M |
| March 31, 2017 | 361.50M |
| December 31, 2016 | 394.30M |
| September 30, 2016 | 459.63M |
| June 30, 2016 | 525.00M |
| March 31, 2016 | 592.51M |
| December 31, 2015 | 386.04M |
| September 30, 2015 | 404.63M |
| June 30, 2015 | 424.70M |
| March 31, 2015 | 438.84M |
| December 31, 2014 | 276.00M |
| September 30, 2014 | 292.51M |
| June 30, 2014 | 311.99M |
| March 31, 2014 | 218.60M |
| December 31, 2013 | 235.12M |
| September 30, 2013 | 245.07M |
| June 30, 2013 | 92.92M |
| March 31, 2013 | 98.70M |
| December 31, 2012 | 102.34M |
| September 30, 2012 | 80.55M |
| June 30, 2012 | 76.98M |
| March 31, 2012 | 68.64M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
172.96M
Minimum
Dec 2019
2.835B
Maximum
Mar 2022
1.805B
Average
1.797B
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
| Pfizer Inc | 216.19B |
| Moderna Inc | 15.68B |
| BioCryst Pharmaceuticals Inc | 472.42M |
| Eli Lilly and Co | 75.61B |
| AIM ImmunoTech Inc | 15.72M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.250B |
| Shareholders Equity (Quarterly) | -431.71M |
| Debt to Equity Ratio | -0.3911 |
| Current Ratio | 1.039 |
| Net Debt Paydown Yield | -0.02% |